Skip to content
GenoLensGenoLens

NR5A1

Chr 9q33.3

nuclear receptor subfamily 5 group A member 1

Aliases:
FTZ1, SF-1, ELP, AD4BP, hSF-1
MANE:
ENST00000373588.9

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Congenital adrenal hypoplasia

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Differences in sex development

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Primary ovarian insufficiency

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • 46,XY sex reversal 3

    0.79
  • premature ovarian failure 7

    0.76
  • spermatogenic failure 8

    0.76
  • 46,XX testicular disorder of sex development

    0.67
  • male infertility with azoospermia or oligozoospermia due to single gene mutation

    0.66
  • 46,XY partial gonadal dysgenesis

    0.64
  • primary ovarian failure

    0.62
  • spermatogenic failure 1

    0.56
  • 46,XY disorder of sex development

    0.55
  • disorder of sexual differentiation

    0.51

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Steroidogenic factor 1

Transcriptional activator. Essential for sexual differentiation and formation of the primary steroidogenic tissues (PubMed:27378692). Binds to the Ad4 site found in the promoter region of steroidogenic P450 genes such as CYP11A, CYP11B and CYP21B. Also regulates the AMH/Muellerian inhibiting substance gene as well as the AHCH and STAR genes. 5'-YCAAGGYC-3' and 5'-RRAGGTCA-3' are the consensus sequences for the recognition by NR5A1 (PubMed:27378692). The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity. Binds phosphatidylcholine (By similarity). Binds phospholipids with a phosphatidylinositol (PI) headgroup, in particular PI(3,4)P2 and PI(3,4,5)P3. Activated by the phosphorylation of NR5A1 by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.